Forum

The CLLAN Community Forum is a closed forum available by invitation to members of the CLL Advocates Network and participants of the 2019 CLL Horizons Conference. The CLL Advocates Network Forum is run by the volunteer steering committee. It is meant to be a place where other CLL advocates can communicate and share with each other. It is a private forum, open exclusively to the above mentioned target groups. Information on this site is meant for educational purposes only and is not meant to replace or give medical advice. We reserve the right to delete any post without explanation. No liability, explicit or implied, shall be extended to the owners or maintainers of this forum for messages posted to the forum.

We are open to suggestions about what our users want. It is your forum – let us know what improvements you would like to see!

Your CLL Advocates Network Team

Home › Forums › CLL – Other Topics › EHA25 virtual CLL Updates

Tagged: 

Viewing 1 post (of 1 total)
  • Author
    Posts
  • 14th June 2020 at 5:54 pm #1697
    Admin
    Keymaster

    Great results from the CLARITY trial with time limited treatment with Ibrutinib and Venetoclax combination in R/R #CLL
    MRD undetectable or low 12 months after stopping treatment in most patients.

    CLL Advocates Network on Twitter_ _Great results from the CLARITY trial with time limited treatment with Ibrutinib and Venetoclax combination in R_R #CLL MRD undetectable or low 12 months after stopping treatment in most patients

  • Author
    Posts
Viewing 1 post (of 1 total)
  • You must be logged in to reply to this topic.